Gambichler, T. http://orcid.org/0000-0001-7862-3695
Said, S.
Abu Rached, N.
Scheel, C. H.
Susok, L.
Stranzenbach, R.
Becker, J. C.
Funding for this research was provided by:
Universitätsklinikum der Ruhr-Universität Bochum
Article History
Received: 7 January 2022
Accepted: 17 January 2022
First Online: 31 January 2022
Declarations
:
: Thilo Gambichler has received speakers and/or advisory board honoraria from BMS, Sanofi-Genzyme, MSD, Novartis Pharma, Roche, Abbvie, Almirall, Janssen, Lilly, Pfizer, Pierre Fabre, Merck-Serono, outside the submitted work. Jürgen C. Becker has received speaker honoraria from Amgen, MerckSerono, Pfizer, Recordati, and Sanofi; advisory board honoraria from 4SC, Amgen, eTheRNA, MerckSerono, Novartis and ReProTher, as well as research funding from Alcedis, Boehringer Ingelheim, Bristol-Myers Squibb, IQVIA, and MerckSerono; he also received travel support from 4SC and Incyte. The other authors declare no conflicts of interest.
: The study was conducted according to the guidelines of the Declaration of Helsinki, and approved by the local Ethics Committee of the Ruhr-University Bochum (IRB Study ID #16-5985).